Status:
COMPLETED
The Short and Long-term Effects of Low Advanced Glycation End Product* Diet
Lead Sponsor:
Marmara University Pendik Training and Research Hospital
Conditions:
Diabetes Type 2
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study was to examine the hypothesis that a diet low in advanced glycation end products (AGE) would provide short and long term improvement in metabolic and inflammatory parameters and ...
Detailed Description
The study included 30 volunteers with type 2 diabetes and 30 healthy participants. During the initial interviews, participants were provided with training on low AGE (advanced glycation end-products) ...
Eligibility Criteria
Inclusion
- To have the competence to adhere to dietary recommendations
Exclusion
- Being \<18 years old or \>65 years old
- Having a history of serious cardiovascular diseases (atrial fibrillation, stroke, ischemic heart disease, peripheral vascular disease, heart failure)
- Having chronic obstructive pulmonary disease
- Smoking
- Having kidney or liver failure
- Having a chronic gastrointestinal disease associated with malabsorption or chronic pancreatitis
- Having a history of rheumatological disease
- Having a history of severe acute illness, malignancy, or alcohol abuse in the last 1 month
- Receiving immunosuppressive treatment
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06005519
Start Date
December 1 2018
End Date
August 30 2021
Last Update
August 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University Istanbul Medical Faculty
Istanbul, Fatih, Turkey (Türkiye), 34096